Nanomedicine-Nanotechnology Biology and Medicine

Papers
(The H4-Index of Nanomedicine-Nanotechnology Biology and Medicine is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein70
Engineered photonic near-infrared light activated photothermal theranostic nanovaccine induced targeted remodeling of tumor microenvironment57
Robust aptamer-targeted CRISPR/Cas9 delivery using mesenchymal stem cell membrane –liposome hybrid: BIRC5 gene knockout against melanoma52
Corrigendum to “A light-up “G-quadruplex nanostring” for label-free and selective detection of miRNA via duplex-specific nuclease mediated tandem rolling circle amplification” [Nanomed.: Nanotechnol. 48
Rational design of nanotherapy for ulcerative colitis: New strategies, mechanistic approaches, and translational challenges41
Macrophage membrane modified baicalin liposomes improve brain targeting for alleviating cerebral ischemia reperfusion injury39
Delivery of gene editing therapeutics38
Preparation of Pt-TiS2 nanocomposite based amperometric glucose biosensor35
Peroxidase modification-driven silymarin liposomes for the treatment of liver fibrosis30
A novel bidirectional perfusion-like administered system for NIR-II fluorescence imaging precision diagnosis of bladder cancer27
Comparative examination of the chemistry and biology of AI-driven gold NPs in Theranostics: New insights into biosensing, bioimaging, genomics, diagnostics, and therapy26
In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study26
Dye labeling for optical imaging biases drug carriers' biodistribution and tumor uptake26
Chemically mediated modification of bacteriophages: Strategies, functionalities and applications in precision medicine26
Electrospun electroconductive constructs of aligned fibers for cardiac tissue engineering25
Intrinsic variability of fluorescence calibrators impacts the assignment of MESF or ERF values to nanoparticles and extracellular vesicles by flow cytometry25
Determination of spectroscopy marker of atherosclerotic carotid stenosis using FTIR-ATR combined with machine learning and chemometrics analyses25
Potential nanotechnology-based diagnostic and therapeutic approaches for Meniere's disease24
Coatsome-replicon vehicles: Self-replicating RNA vaccines against infectious diseases24
A novel treatment for diabetic nephropathy: Folate receptor-targeted delivery of TLR4 siRNA via functionalized PLGA nanoparticles in streptozotocin-induced diabetic murine models23
Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules23
PLGA-Based nanocarriers in drug delivery: Advances in block copolymer engineering, hybrid platforms, and clinical translation23
Corrigendum to “Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia” [Nanomedicine 40 (2022 Feb); 102480. doi: 10.1016/j.nano.2021.102480]22
0.56135892868042